NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease

INTRODUCTION: This study is a European multicentre, randomised, double-blind, placebo-controlled trial investigating the efficacy and safety of nilvadipine as a disease course modifying treatment for mild-to-moderate Alzheimer's disease (AD) in a phase III study that will run for a period of 82...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawlor, Brian, Kennelly, Sean, O'Dwyer, Sarah, Cregg, Fiona, Walsh, Cathal, Coen, Robert, Kenny, Rose Anne, Howard, Robert, Murphy, Caroline, Adams, Jessica, Daly, Leslie, Segurado, Ricardo, Gaynor, Siobhan, Crawford, Fiona, Mullan, Michael, Lucca, Ugo, Banzi, Rita, Pasquier, Florence, Breuilh, Laetitia, Riepe, Matthias, Kalman, Janos, Wallin, Anders, Borjesson, Anne, Molloy, William, Tsolaki, Magda, Olde Rikkert, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Geriatric Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194801/
https://www.ncbi.nlm.nih.gov/pubmed/25300460
http://dx.doi.org/10.1136/bmjopen-2014-006364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194801/
https://www.ncbi.nlm.nih.gov/pubmed/25300460
http://dx.doi.org/10.1136/bmjopen-2014-006364

Ejemplares similares